Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118233) titled 'Clinical Study on Roxadustat Improving Anemia of Inflammation' on Feb. 3.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Beijing Chao-Yang Hospital, Capital Medical University
Condition:
Inflammatory anemia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-03
Target Sample Size: The roxadustat treatment observation group:43;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300793
Disclaimer: Curated by HT Syndication....